Zhejiang Tianyu Pharmaceutical Co Ltd
SZSE:300702
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
|
US |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Walmart Inc
NYSE:WMT
|
Retail
|
|
US |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
13.74
21.93
|
Price Target |
|
We'll email you a reminder when the closing price reaches CNY.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Mastercard Inc
NYSE:MA
|
US | |
UnitedHealth Group Inc
NYSE:UNH
|
US | |
Exxon Mobil Corp
NYSE:XOM
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Walmart Inc
NYSE:WMT
|
US | |
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Zhejiang Tianyu Pharmaceutical Co Ltd
Accrued Liabilities
Zhejiang Tianyu Pharmaceutical Co Ltd
Accrued Liabilities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Company | Accrued Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
---|---|---|---|---|---|---|
Z
|
Zhejiang Tianyu Pharmaceutical Co Ltd
SZSE:300702
|
Accrued Liabilities
ÂĄ74.2m
|
CAGR 3-Years
-3%
|
CAGR 5-Years
7%
|
CAGR 10-Years
N/A
|
|
H
|
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
|
Accrued Liabilities
ÂĄ2B
|
CAGR 3-Years
2%
|
CAGR 5-Years
14%
|
CAGR 10-Years
N/A
|
|
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
|
Accrued Liabilities
ÂĄ620.1m
|
CAGR 3-Years
74%
|
CAGR 5-Years
53%
|
CAGR 10-Years
31%
|
||
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
|
Accrued Liabilities
ÂĄ128.5m
|
CAGR 3-Years
456%
|
CAGR 5-Years
130%
|
CAGR 10-Years
63%
|
||
Yunnan Baiyao Group Co Ltd
SZSE:000538
|
Accrued Liabilities
ÂĄ1.5B
|
CAGR 3-Years
74%
|
CAGR 5-Years
54%
|
CAGR 10-Years
46%
|
||
S
|
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
|
Accrued Liabilities
ÂĄ146m
|
CAGR 3-Years
-11%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
Zhejiang Tianyu Pharmaceutical Co Ltd
Glance View
Zhejiang Tianyu Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of chemical raw materials and intermediates. The company is headquartered in Taizhou, Zhejiang and currently employs 4,991 full-time employees. The company went IPO on 2017-09-19. The firm operates three segments. The Pharmaceutical Intermediates segment include hypertension drugs raw materials, anti-asthma drugs raw materials and anticoagulant drugs raw materials. The Active Pharmaceutical Ingredients (API) segment is engaged in production of high blood pressure drug intermediates, anti-asthma drug intermediates and antiviral drug intermediates. The firm also operates Other segment. The firm sells its products to both domestic and international markets, including Europe, the United States, Japan, South Korea and so on.
See Also
What is Zhejiang Tianyu Pharmaceutical Co Ltd's Accrued Liabilities?
Accrued Liabilities
74.2m
CNY
Based on the financial report for Sep 30, 2024, Zhejiang Tianyu Pharmaceutical Co Ltd's Accrued Liabilities amounts to 74.2m CNY.
What is Zhejiang Tianyu Pharmaceutical Co Ltd's Accrued Liabilities growth rate?
Accrued Liabilities CAGR 5Y
7%
Over the last year, the Accrued Liabilities growth was 11%. The average annual Accrued Liabilities growth rates for Zhejiang Tianyu Pharmaceutical Co Ltd have been -3% over the past three years , 7% over the past five years .